{"id":4681,"date":"2016-09-08T14:28:35","date_gmt":"2016-09-08T05:28:35","guid":{"rendered":"https:\/\/www.3rockconsulting.com\/wordpress\/?p=4681"},"modified":"2019-05-21T14:30:01","modified_gmt":"2019-05-21T05:30:01","slug":"201610digitalpharma_jpn","status":"publish","type":"post","link":"https:\/\/www.3rockconsulting.com\/en\/event\/201610digitalpharma_jpn\/","title":{"rendered":"[October] &#8220;Digital Pharma Now 2016&#8221; (Program Completed)"},"content":{"rendered":"<p>With increasing restrictions on MR visits, expanding application of community health initiatives, and increasing cost awareness among stakeholders, pharma companies have been driven to adopt new digitally-enabled approaches.<br \/>\nWhich of these are proving to be effective? The answers are not yet clear, and all companies are piloting to some extent. This seminar will explore recent market movements from a variety of perspectives, in order to help attendees learn about options and make better choices.<br \/>\nPlease join us to learn how to plan your digital initiatives going forward, and gather hints to help your strategy succeed!<br \/>\nContent will also include take-aways from the Stanford University &#8220;Medicine X&#8221; event being held in September in the US.<br \/>\n<\/p>\n<dl>\n<dt><b>\u25b6 Contents<\/b><\/dt>\n<p>\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501<\/p>\n<dd>1) Leveraging New Channel \/ MCM\uff08Multi Channel Marketing\uff09<\/dd>\n<dd>2) Message customization in the digital age<\/dd>\n<dd>3) Things to watch out for in planning your new launch<\/dd>\n<dd>4) The future of patient &#038; family support programs<\/dd>\n<dd>5) Points to consider regarding digital Real-World Data (RWD)<\/dd>\n<dd>6) Global cutting-edge practices and their evaluation<\/dd>\n<\/dl>\n<p><\/p>\n<dl>\n<dt><b>\u25b6 Place:<\/b><\/dt>\n<p>\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501<\/p>\n<dd>Nihonbashi Life Science Hub (Muromachi Chibagin Mitsui Building, 8F)<\/dd>\n<dd>\u25cfAddress<\/dd>\n<dd>Muromachi 1-5-5, Nihonbashi, Chuo-ku, Tokyo<\/dd>\n<dd><a href=\"https:\/\/www.nihonbashi-lifescience.jp\/en\/\"target=\"_blank\" rel=\"noopener noreferrer\">\u25cfMap<\/a><\/dd>\n<p><\/p>\n<dl>\n<dt><b>\u25b6 Cost<\/b><\/dt>\n<p>\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501<\/p>\n<dd>30,000 JPY (after tax)<\/dd>\n<\/dl>\n<p>&nbsp;<br \/>\n<b>\u25b6 Application<\/b><br \/>\n\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501<br \/>\nProgram Completed.<br \/>\n&nbsp;<\/p>\n<dd>\u203bClick <a href=\"..\/..\/..\/pdf\/2016_digitalpharma_all.pdf\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>HERE<\/strong><\/a> for details.<\/dd>\n<p>\n<b>\u25b6 For inquiries, click <a href=\"\/en\/contact\/\">HERE<\/a><\/b><br \/>\n<br \/>\n&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>With increasing restrictions on MR visits, expanding application of community health initiatives, and increasing cost awareness among stakeholders, pharma companies have been driven to adopt new digitally-enabled approaches. Which of these are proving to be effective? The answers are not yet clear, and all companies are piloting to some extent. This seminar will explore recent market movements from a variety &#8230; <\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"_locale":"en_US","_original_post":"2101"},"categories":[9,4],"tags":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.3rockconsulting.com\/wp-json\/wp\/v2\/posts\/4681"}],"collection":[{"href":"https:\/\/www.3rockconsulting.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.3rockconsulting.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.3rockconsulting.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.3rockconsulting.com\/wp-json\/wp\/v2\/comments?post=4681"}],"version-history":[{"count":0,"href":"https:\/\/www.3rockconsulting.com\/wp-json\/wp\/v2\/posts\/4681\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.3rockconsulting.com\/wp-json\/wp\/v2\/media?parent=4681"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.3rockconsulting.com\/wp-json\/wp\/v2\/categories?post=4681"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.3rockconsulting.com\/wp-json\/wp\/v2\/tags?post=4681"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}